Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis.

Primary biliary cholangitis (PBC) is a common condition that usually shows a progressive course towards cirrhosis without adequate treatment. Growth differentiation factor 15 (GDF15) plays multiple roles in various pathological conditions. The overall role of circulating GDF15 in cirrhotic PBC requi...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 12
Autores principales: Li, Zhanyi, Liu, Yu, Li, Xiangyong, Wu, Yuankai, Yang, Fangji, Mo, Qiwan, Chong, Yutian
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 10/29/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146704755&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 146704755
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 10/29/2020
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        146704755
        146704755
        146704755
        10.1155/2020/5162541
        146704755
      ppf: 1
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis.
      aug:
        au:
          Li, Zhanyi
          Liu, Yu
          Li, Xiangyong
          Wu, Yuankai
          Yang, Fangji
          Mo, Qiwan
          Chong, Yutian
        affil: Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China
      sug:
        subj:
          Cholangitis Physiopathology
          Liver Cirrhosis Physiopathology
          Cytokines Blood
          Cholangitis Prognosis
          Liver Cirrhosis Prognosis
          Biological Markers Blood
          Growth Differentiation Factors
          Human
          Immunoenzyme Techniques
          Body Weight Changes
          Albumins Blood
          Bilirubin Blood
          Bile Acids and Salts Blood
          Descriptive Statistics
          C-Reactive Protein Blood
          ROC Curve
          Liver Cirrhosis Diagnosis
          Sensitivity and Specificity
          Severity of Illness Indices
          Biochemical Phenomena
      ab: Primary biliary cholangitis (PBC) is a common condition that usually shows a progressive course towards cirrhosis without adequate treatment. Growth differentiation factor 15 (GDF15) plays multiple roles in various pathological conditions. The overall role of circulating GDF15 in cirrhotic PBC requires further investigation. Twenty patients with cirrhotic PBC, 26 with non-cirrhotic PBC, and 10 healthy subjects were enrolled between 2014 and 2018, and the serum levels of GDF15 were measured via enzyme immunoassay. The correlations between serum GDF15, weight, biochemical parameters, and the prognosis were analysed. Serum levels of GDF15 were significantly higher in cirrhotic PBC patients than in non-cirrhotic PBC patients or healthy controls (p = 0.009 and p < 0.001 , respectively). The circulating GDF15 levels strongly correlated with weight changes (r = − 0.541 , p = 0.0138), albumin (r = − 0.775 , p < 0.0001), direct bilirubin (r = − 0.786 , p < 0.0001), total bile acids (r = 0.585 , p = 0.007), and C-reactive protein (r = 0.718 , p = 0.0005). Moreover, circulating GDF15 levels strongly correlated with the Mayo risk score (r = 0.685 , p = 0.0009) and Model for End-stage Liver Disease score (r = 0.687 , p = 0.0008). Determined by the area under the receiver operating characteristic curves, the overall diagnostic accuracies of GDF15 were as follows: cirrhosis = 0.725 (>3646.55 pg/mL, sensitivity: 70.0%, specificity: 69.2%), decompensated cirrhosis = 0.956 (>4073.30 pg/mL, sensitivity: 84.62%, specificity: 100%), and cirrhotic biochemical non-responders = 0.835 (>3479.20 pg/mL, sensitivity: 71.43%, specificity: 92.31%). GDF15 may be a useful and integrated biochemical marker to evaluate not only the disease severity and prognosis but also the nutrition and response to treatment of cirrhotic PBC patients, and its overall performance is satisfactory. Therapy targeting GDF15 is likely to benefit cirrhotic PBC patients and is worth further research.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N